110 related articles for article (PubMed ID: 24804368)
1. Usefulness of lipid ratios and atherogenic index of plasma in obese Moroccan women with or without metabolic syndrome.
Essiarab F; Taki H; Lebrazi H; Sabri M; Saïle R
Ethn Dis; 2014; 24(2):207-12. PubMed ID: 24804368
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
3. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
Dobiásová M; Frohlich J
Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517
[TBL] [Abstract][Full Text] [Related]
4. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation.
Venojärvi M; Korkmaz A; Wasenius N; Manderoos S; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
Food Chem Toxicol; 2013 Nov; 61():127-35. PubMed ID: 23623841
[TBL] [Abstract][Full Text] [Related]
5. The correlation between dietary fat quality indices and lipid profile with Atherogenic index of plasma in obese and non-obese volunteers: a cross-sectional descriptive-analytic case-control study.
Moussavi Javardi MS; Madani Z; Movahedi A; Karandish M; Abbasi B
Lipids Health Dis; 2020 Sep; 19(1):213. PubMed ID: 32979928
[TBL] [Abstract][Full Text] [Related]
6. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of the Modified Atherogenic Index of Plasma during Body Mass Reduction in Polish Obese/Overweight People.
Zalejska-Fiolka J; Hubková B; Birková A; Veliká B; Puchalska B; Kasperczyk S; Błaszczyk U; Fiolka R; Bożek A; Maksym B; Mareková M; Birkner E
Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30591697
[TBL] [Abstract][Full Text] [Related]
8. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects.
Esteghamati A; Noshad S; Khalilzadeh O; Morteza A; Nazeri A; Meysamie A; Esteghamati A; Nakhjavani M
Arch Med Res; 2011 Apr; 42(3):244-51. PubMed ID: 21722822
[TBL] [Abstract][Full Text] [Related]
9. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.
Hernández-Mijares A; Bañuls C; Gómez-Balaguer M; Bergoglio M; Víctor VM; Rocha M
Eur J Clin Invest; 2013 Jun; 43(6):549-56. PubMed ID: 23528141
[TBL] [Abstract][Full Text] [Related]
10. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China.
Zhu X; Yu L; Zhou H; Ma Q; Zhou X; Lei T; Hu J; Xu W; Yi N; Lei S
Lipids Health Dis; 2018 Mar; 17(1):37. PubMed ID: 29506577
[TBL] [Abstract][Full Text] [Related]
12. [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice].
Dobiásová M
Vnitr Lek; 2006 Jan; 52(1):64-71. PubMed ID: 16526201
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
[TBL] [Abstract][Full Text] [Related]
14. Association of plasma viscosity with cardiovascular risk factors in obesity: an old marker, a new insight.
Ercan M; Konukoglu D; Erdem Yeşim T
Clin Hemorheol Microcirc; 2006; 35(4):441-6. PubMed ID: 17148842
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
Christodoulakos GE; Lambrinoudaki IV; Economou EV; Papadias C; Panoulis CP; Kouskouni EE; Vlachou SA; Creatsas GC
J Cardiovasc Pharmacol; 2006 Apr; 47(4):542-8. PubMed ID: 16680067
[TBL] [Abstract][Full Text] [Related]
16. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
17. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
18. Lipid profile in obesity.
Bhatti MS; Akbri MZ; Shakoor M
J Ayub Med Coll Abbottabad; 2001; 13(1):31-3. PubMed ID: 11706638
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype.
Jové M; Naudí A; Portero-Otin M; Cabré R; Rovira-Llopis S; Bañuls C; Rocha M; Hernández-Mijares A; Victor VM; Pamplona R
FASEB J; 2014 Dec; 28(12):5163-71. PubMed ID: 25169057
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus.
Zhu XW; Deng FY; Lei SF
Prim Care Diabetes; 2015 Feb; 9(1):60-7. PubMed ID: 24810146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
